Analyst Ratings for Biogen (BiIB)
BiIB Rating Summary
BiIB Price Target Summary
- Highest: $300.00 (Oppenheimer)
- Lowest: $150.00 (HSBC)
- Average: $218.96
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$218.96 (+9.1%)
* Over Last 12-Mos
Rating Score: 5.9 / 10
Percentile Rank: 62%
Avg. $ Target:
$218.96 (+9.1%)
* Over Last 12-Mos
Rating Score: 5.9 / 10
Percentile Rank: 62%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/8/2026 | Needham » Updated 6/18/2026 |
Ami Fadia | Upgrade | Buy (Hold) |
255.00 (N/A) |
195.34 (200.65) |
2.72% | Details |
| 5/14/2026 | Evercore ISI | Umer Raffat | New Coverage | Outperform (N/A) |
N/A (N/A) |
204.53 (200.65) |
-1.9% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
